long half-life and large variability [Regulatives / Guidelines]

posted by dshah – India, 2020-08-10 04:18 (204 d 00:50 ago) – Posting: # 21846
Views: 1,238

Hi All!

I believe there are few MR drug with high variability and still USFDA recommends partial or fully replicate design. Mesalamine PSG or
Mesalamine PSG for 800 mg strength
Considering the Mechanism of Action, PK variability, non-Linearity- the study and formultion could indeed be challenging.

Regards,
Dshah

Complete thread:

Activity
 Admin contact
21,358 posts in 4,459 threads, 1,492 registered users;
online 5 (0 registered, 5 guests [including 3 identified bots]).
Forum time: Tuesday 05:08 UTC (Europe/Vienna)

The interpretation of facts in a certain way
stimulates other scientists’ thoughts.    Róbert Bárány

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5